JANX
NASDAQ · Biotechnology
Janux Therapeutics Inc
$16.06
-2.12 (-11.66%)
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Price Target
Analyst Price Target
+205.7% upside
Low Target
$33.46
Average Target
$49.10
High Target
$61.24
Current Price
$16.06
Current
$16.06
$16.06
Target
$49.10
$49.10
$33.46
$49.10 avg
$61.24
Scenario Analysis
Bear Case
$33.46
108.3%
Low target
Base Case
$49.10
+205.7%
Avg target
Bull Case
$61.24
+281.3%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$35.34
-54.6% from high
52-Week Low
$12.12
+32.5% from low
Target vs 52W High
$49.10
+38.9% vs high
Next Earnings Report
Nov 10, 2026 · After Market Close
2d
until earnings
EPS Est: $-0.48
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |